Correlation Between Abcellera Biologics and Scandinavian Tobacco

Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Scandinavian Tobacco at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Scandinavian Tobacco into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abcellera Biologics and Scandinavian Tobacco Group, you can compare the effects of market volatilities on Abcellera Biologics and Scandinavian Tobacco and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Scandinavian Tobacco. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Scandinavian Tobacco.

Diversification Opportunities for Abcellera Biologics and Scandinavian Tobacco

-0.51

Correlation Coefficient

Abcellera Biologics  Scandinavian Tobacco

Excellent diversification

The 3 months correlation between Abcellera and Scandinavian is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Scandinavian Tobacco Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scandinavian Tobacco and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Scandinavian Tobacco. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scandinavian Tobacco has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Scandinavian Tobacco go up and down completely randomly.

Pair Corralation between Abcellera Biologics and Scandinavian Tobacco

If you would invest  265.00  in Abcellera Biologics on September 19, 2024 and sell it today you would earn a total of  4.00  from holding Abcellera Biologics or generate 1.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Abcellera Biologics  vs.  Scandinavian Tobacco Group

Abcellera Biologics

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Abcellera Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent fundamental indicators, Abcellera Biologics is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Scandinavian Tobacco

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Scandinavian Tobacco Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical and fundamental indicators, Scandinavian Tobacco is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Abcellera Biologics and Scandinavian Tobacco

The main advantage of trading using opposite Abcellera Biologics and Scandinavian Tobacco positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Scandinavian Tobacco can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scandinavian Tobacco will offset losses from the drop in Scandinavian Tobacco's long position.

The idea behind Abcellera Biologics and Scandinavian Tobacco Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.